Laura Ila von Schantz
Chief Tech/Sci/R&D Officer at ALLIGATOR BIOSCIENCE AB
Network origin in Laura Ila von Schantz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Laura Ila von Schantz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree Doctorate Degree | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman | |
| A Bioscience Incentive AB | Chairman Chairman Director/Board Member Director/Board Member Director/Board Member | ||
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Investor Relations Contact Director/Board Member | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Founder Director/Board Member Investor Relations Contact | |
PainDrainer AB
 PainDrainer AB Packaged SoftwareTechnology Services PainDrainer AB is a Swedish medical technology company that helps people with chronic pain achieve a better quality of life and activity balance. The company is based in Lund, Sweden. The company's app is based on seven categories that have a scientifically proven impact on pain levels. Users can choose what they want to do more of in their lives, and the app helps them achieve their goals. PainDrainer has been shown to have a scientifically documented effect in many clinical studies and is a CE-marked medical technical app. The CEO of the company is Erik Frick. | Packaged Software | Chairman Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Public Communications Contact Director/Board Member | |
| ABLIVA AB | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CMC SPV of 3 April 2017 AB | Director/Board Member Director/Board Member | ||
| Handelshögskolan i Göteborg | College/University | Masters Business Admin Graduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Investment Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| STORYTEL AB | Publishing: Books/Magazines | Director/Board Member Director/Board Member | |
| Spiber Technologies AB | Director/Board Member Chairman | ||
ApoEx AB
 ApoEx AB Medical DistributorsDistribution Services ApoEx AB offers products and services to healthcare industry. The firm provides services for dentistry, aesthetic surgery and medical care, animal care, and government. The company was founded by Jens-Leo Hubertus Berlips and John Patrick Berlips in 2010 and is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Director of Finance/CFO | |
| DICOT AB | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
| XSpray Pharma Futurum AB | Corporate Officer/Principal | ||
| Save Depa AB | Director/Board Member | ||
Save Flygplats Fastigheter AB
 Save Flygplats Fastigheter AB Real Estate DevelopmentFinance Save Flygplats Fastigheter AB is a Swedish company that rents and manages real estate properties. | Real Estate Development | Director/Board Member | |
Nolvik Hotell & Konferens AB
 Nolvik Hotell & Konferens AB Hotels/Resorts/Cruise linesConsumer Services Nolvik Hotell & Konferens AB operates hotels. | Hotels/Resorts/Cruise lines | Director/Board Member | |
Save Utveckling AB
 Save Utveckling AB Real Estate DevelopmentFinance Save Utveckling AB is a Swedish company that specializes in the rental and management of leased real estate properties. | Real Estate Development | Director/Board Member | |
| Genova Dvargspetsen AB | Director/Board Member | ||
| Genova Drevern AB | Director/Board Member | ||
| Beambox AB | Director/Board Member | ||
Infranord AB
 Infranord AB Engineering & ConstructionIndustrial Services Infranord AB is a railway contractor that builds and maintains railways. The private company is based in Solna, Sweden and has subsidiaries in Norway. Infranord offers training that gives authorization to stay and work on SL's tracks and provides track machines and workshop services to the entire market. The Swedish company is characterized by solid railway knowledge, high safety, and extensive investments in being the industry's most valued employer. Henrik Löfgren has been the CEO of the company since 2019. | Engineering & Construction | Director/Board Member | |
| ATRIUM LJUNGBERG AB | Real Estate Development | Director of Finance/CFO | |
| PANDOX AB | Real Estate Development | Director/Board Member | |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
| KALLEBÄCK PROPERTY INVEST AB | Real Estate Development | Director/Board Member | |
| NYFOSA AB | Real Estate Development | Director/Board Member | |
| EIT Electroinvest Trading SA | Corporate Officer/Principal | ||
| Save Flygplatsdrift AB | Director/Board Member | ||
| IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Apotekets Omstrukturering AB | Chief Executive Officer | ||
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Chairman | |
| The Swedish Academy | Chairman |
Statistics
International
| Sweden | 45 |
| Denmark | 5 |
| United Kingdom | 2 |
| United States | 2 |
Sectoral
| Health Technology | 21 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 207 |
| Corporate Officer/Principal | 62 |
| Chairman | 61 |
| Independent Dir/Board Member | 36 |
| Chief Tech/Sci/R&D Officer | 22 |
Most connected contacts
- Stock Market
- Insiders
- Laura Ila von Schantz
- Company connections